1. Home
  2. RENX vs BMRA Comparison

RENX vs BMRA Comparison

Compare RENX & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RenX Enterprises Corp. Common Stock

RENX

RenX Enterprises Corp. Common Stock

N/A

Current Price

$2.86

Market Cap

6.7M

Sector

N/A

ML Signal

N/A

Logo Biomerica Inc.

BMRA

Biomerica Inc.

HOLD

Current Price

$2.10

Market Cap

6.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RENX
BMRA
Founded
2021
1971
Country
United States
United States
Employees
38
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7M
6.6M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
RENX
BMRA
Price
$2.86
$2.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.5M
23.2K
Earning Date
05-22-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,311,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.09
$0.40
52 Week High
$3.48
$4.60

Technical Indicators

Market Signals
Indicator
RENX
BMRA
Relative Strength Index (RSI) 71.88 47.46
Support Level $0.12 $1.91
Resistance Level $3.48 $2.23
Average True Range (ATR) 0.41 0.09
MACD 0.10 0.00
Stochastic Oscillator 79.92 51.85

Price Performance

Historical Comparison
RENX
BMRA

About RENX RenX Enterprises Corp. Common Stock

RenX Enterprises Corp is a real estate development and environmental solutions company. It is focused on the direct acquisition and indirect investment in properties across the United States that are intended for development into green single-family or multifamily housing projects. The company also focuses on the monetization of its real estate assets. It processes source-separated green waste and is expanding into the production of sustainable, high-margin potting media and soil substrates through advanced milling technology.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

Share on Social Networks: